XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 1 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $1,972,000 | 0.0% | 805,027 | +66.2% | 0.00% | – |
| Q2 2021 | $1,972,000 | -4.2% | 484,432 | +6.1% | 0.00% | – |
| Q1 2021 | $2,058,000 | -62.5% | 456,400 | -59.0% | 0.00% | – |
| Q4 2020 | $5,484,000 | +122.6% | 1,114,510 | +168.2% | 0.00% | – |
| Q3 2020 | $2,464,000 | +7366.7% | 415,500 | +3253.0% | 0.00% | – |
| Q2 2020 | $33,000 | +3.1% | 12,392 | -25.0% | 0.00% | – |
| Q1 2020 | $32,000 | -83.8% | 16,518 | -17.6% | 0.00% | – |
| Q3 2019 | $197,000 | -16.5% | 20,039 | -3.1% | 0.00% | – |
| Q2 2019 | $236,000 | – | 20,678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,000,641 | $29,496,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,308,666 | $22,694,000 | 0.92% |
| ArrowMark Colorado Holdings LLC | 1,656,422 | $16,283,000 | 0.16% |
| IHT Wealth Management, LLC | 57,028 | $561,000 | 0.08% |
| MOORE CAPITAL MANAGEMENT, LP | 50,000 | $492,000 | 0.02% |
| Engineers Gate Manager LP | 20,264 | $199,000 | 0.01% |
| FEDERATED HERMES, INC. | 300,000 | $2,949,000 | 0.01% |
| FMR LLC | 4,048,102 | $39,793,000 | 0.01% |
| Invesco Ltd. | 1,000,000 | $9,830,000 | 0.00% |
| MetLife Investment Management, LLC | 14,041 | $138,023 | 0.00% |